SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008513
Filing Date
2022-05-09
Accepted
2022-05-09 16:23:39
Documents
91
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crbu-20220331.htm   iXBRL 10-Q 2651026
2 EX-31.1 crbu-ex31_1.htm EX-31.1 19240
3 EX-31.2 crbu-ex31_2.htm EX-31.2 19234
4 EX-32.1 crbu-ex32_1.htm EX-32.1 11371
5 EX-32.2 crbu-ex32_2.htm EX-32.2 11360
  Complete submission text file 0000950170-22-008513.txt   12015742

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbu-20220331_cal.xml EX-101.CAL 52627
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20220331_lab.xml EX-101.LAB 607052
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20220331_pre.xml EX-101.PRE 490093
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbu-20220331_def.xml EX-101.DEF 276686
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20220331.xsd EX-101.SCH 78834
85 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20220331_htm.xml XML 2736618
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40631 | Film No.: 22905390
SIC: 2836 Biological Products, (No Diagnostic Substances)